n-((2-dimethylamino)ethyl)-9-aminoacridine-4-carboxamide has been researched along with Leukemia L 1210 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atwell, GJ; Baguley, BC; Chambers, D; Denny, WA; Rewcastle, GW | 1 |
Atwell, GJ; Baguley, BC; Cain, BF; Denny, WA; Finlay, GJ | 1 |
2 other study(ies) available for n-((2-dimethylamino)ethyl)-9-aminoacridine-4-carboxamide and Leukemia L 1210
Article | Year |
---|---|
Potential antitumor agents. 46. Structure-activity relationships for acridine monosubstituted derivatives of the antitumor agent N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide.
Topics: Aminoacridines; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Chromatography, Liquid; Colonic Neoplasms; DNA; Humans; Leukemia L1210; Lung Neoplasms; Mice; Structure-Activity Relationship | 1986 |
Potential antitumor agents. 43. Synthesis and biological activity of dibasic 9-aminoacridine-4-carboxamides, a new class of antitumor agent.
Topics: Adenocarcinoma; Aminoacridines; Animals; Antineoplastic Agents; Cell Line; DNA; Humans; Leukemia L1210; Leukemia P388; Male; Mice; Mice, Inbred DBA | 1984 |